Results 1 to 10 of about 9,207,506 (367)

Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne), 2023
Purpose A systematic review and meta-analysis was conducted to synthesize the available data from clinical trials and assess the safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes (T2D) and obesity.
Zeng Q, Xu J, Mu X, Shi Y, Fan H, Li S.
europepmc   +2 more sources

Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors. [PDF]

Nat Commun, 2020
The number of patients diagnosed with chronic bile duct disease is increasing and in most cases these diseases result in chronic ductular scarring, necessitating liver transplantation.
Wilson DH, Jarman EJ, Mellin RP, Wilson ML, Waddell SH, Tsokkou P, Younger NT, Raven A, Bhalla SR, Noll ATR, Olde Damink SW, Schaap FG, Chen P, Bates DO, Banales JM, Dean CH, Henderson DJ, Sansom OJ, Kendall TJ, Boulter L.   +19 more
europepmc   +2 more sources

Mirizzi Syndrome: Diagnosis and Management of a Challenging Biliary Disease. [PDF]

Can J Gastroenterol Hepatol, 2018
Background Mirizzi syndrome is a condition difficult to diagnose and treat, representing a particular “challenge” for the biliary surgeon. The disease can mimic cancer of the gallbladder, causing considerable diagnostic difficulties.
Clemente G, Tringali A, De Rose AM, Panettieri E, Murazio M, Nuzzo G, Giuliante F.   +6 more
europepmc   +2 more sources

Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. [PDF]

Diabetes Care, 2019
OBJECTIVE To explore gallbladder- and biliary tract–related events reported for the liraglutide and placebo groups in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial.
Nauck MA, Muus Ghorbani ML, Kreiner E, Saevereid HA, Buse JB, LEADER Publication Committee on behalf of the LEADER Trial Investigators.   +5 more
europepmc   +2 more sources

Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos).

Endosc Ultrasound, 2019
Background and Objectives: Biliary drainage (BD) under EUS guidance is usually indicated for malignant biliary obstruction. Recently, EUS-guided transluminal treatment has been applied to benign biliary disease (BBD). This multicenter retrospective study
Ogura T, Takenaka M, Shiomi H, Goto D, Tamura T, Hisa T, Kato H, Nishioka N, Minaga K, Masuda A, Onoyama T, Kudo M, Higuchi K, Kitano M.   +13 more
europepmc   +2 more sources

Pathological patterns of biliary disease. [PDF]

Clin Liver Dis (Hoboken), 2017
Lewis J.
europepmc   +2 more sources

Economic cost analysis of cholecystectomy based on development of specialization [PDF]

Waike lilun yu shijian, 2022
Object To analyze the difference of economics cost between biliary surgeons and general surgeons in performing cholecystectomy for gallbladder benign diseases and the influence of specialization of surgery on patients.
SHEN Sheng, GAO Zhihui, XIN Yanlei, ZHENG Bohao, LIU Houbao, SUO Tao
doaj   +1 more source

Statistical declarations versus scientific inferences and clinical judgments: the association of Glucagon-like peptide-1 receptor agonist use with the risk of biliary disease [PDF]

Frontiers in Endocrinology
David E. Most
doaj   +2 more sources

Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity score-matched analysis

Biomolecules & Biomedicine, 2023
Gallbladder neuroendocrine carcinoma (GBNEC) is rare and characterized by a low degree of tumor differentiation. The clinical features of GBNEC versus gallbladder adenocarcinoma (GBADC) remain a subject of debate.
Ya-Fei Hu, Wen-Jie Ma, Hai-Jie Hu, Han-Fei Gu, Yan-Wen Jin, Fu-Yu Li   +5 more
doaj   +1 more source

Design and Development of a Disposable Superfine Catheter for Visual Examination of Bile Ducts and Related Animal Experiments

Frontiers in Surgery, 2022
ObjectiveTo design and develop a disposable superfine catheter system for visual examination of bile and pancreatic ducts and predict its clinical application value.MethodsThe superfine triple-lumen catheter and miniature photography technology were used
Jin-Yong Hao, Jin-Yong Hao, Yao-Ping Zhang, Xiao-Jun Huang, Xiao-Jun Huang   +4 more
doaj   +1 more source